Evidence map›Paper›PMID 22130817›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2011

The role of the right ventricle in pulmonary arterial hypertension.

A Vonk Noordegraaf, N Galiè

2 registry-linked trialsOpen access · diamondAbstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 122 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed, 1 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04554160 unknown statusnot on this mapstarted 2018, after this paper: background citation

ArrhythmiaS in Pulmonary arterIal hypeRtEnsion and Right Heart Failure Assessed by Continuous Long-term Cardiac Monitoring

TypeobservationalSponsorRigshospitalet, DenmarkRan2018 to 2024Enrolled40ConditionsPulmonary Hypertension, Arrhythmias, Cardiac, Heart Rate Variability, Risk AssessmentArmsLoop recorder implantation, A smartwatch
NCT04732663 completednot on this mapstarted 2021, after this paper: background citation

Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19

TypeobservationalSponsorUniversity of AlbertaRan2021 to 2024Enrolled64ConditionsCovid19, DyspneaArmsNo Intervention
3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 1 synthesis or guideline pooled it, 254 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Observational
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

A Vonk NoordegraafVU University Medical Center, Amsterdam, The Netherlands. a.vonk@vumc.nl
N Galiè
Amsterdam UMC Location VUmc · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although changes in the pulmonary vasculature are the primary cause of pulmonary arterial hypertension (PAH), severity of symptoms and survival are strongly associated with right ventricular function, and right heart failure is the main cause of death in patients with PAH. Echocardiography and cardiac magnetic resonance imaging allow noninvasive evaluation of right ventricular function and structure, and a number of indices have been shown to have potential prognostic value in PAH. Given the importance of the right ventricle in PAH, preservation and improvement of its function should be important aspects of therapy; however, there are currently few data specifically related to this aspect of treatment response. Simple, reproducible, noninvasive measures of right ventricular function would help to improve the management of patients with PAH, and to provide tools with which to help establish the optimal therapeutic approach to manage not only the effects of the disease on the pulmonary vasculature, but also to support and improve right ventricular function.

Indexed as

Severity of Illness IndexEchocardiographyFamilial Primary Pulmonary HypertensionHumansHypertension, PulmonaryKaplan-Meier EstimateLungMagnetic Resonance ImagingPrognosisVentricular Dysfunction, Right

Identifiers

PMID22130817
PMCPMC9487747
OpenAlexW2155720896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.